Desq Long
Sign in

Company

ANI PHARMACEUTICALS INC

ANIP · CIK 0001023024

SEC FORM 4
$383,400.00

ANI PHARMACEUTICALS INC (ANIP)

Sale of 5,400 shares at $71 per share.

Reporting Person Lalwani Nikhil · Officer Title PRESIDENT & CEO · Transaction Code S

Traded Sep 15, 2026 · Disclosed Sep 16, 2026

Source: SEC Form 4 · 0001822629-26-000016 · filed 2026-09-16 · View filing →

SEC FORM 4
$35,395.00

ANI PHARMACEUTICALS INC (ANIP)

Sale of 500 shares at $70.79 per share.

Reporting Person Cook Meredith · Officer Title SR. VP, GENERAL COUNSEL & SEC. · Transaction Code S

Traded Sep 14, 2026 · Disclosed Sep 14, 2026

Source: SEC Form 4 · 0001938861-26-000026 · filed 2026-09-14 · View filing →

SEC FORM 4
$71,530.00

ANI PHARMACEUTICALS INC (ANIP)

Sale of 1,000 shares at $71.53 per share.

Reporting Person Thoma Jeanne · Transaction Code S

Traded Sep 11, 2026 · Disclosed Sep 14, 2026

Source: SEC Form 4 · 0001819879-26-000006 · filed 2026-09-14 · View filing →

SEC FORM 4
$207,480.00

ANI PHARMACEUTICALS INC (ANIP)

Sale of 2,850 shares at $72.80 per share.

Reporting Person CAREY STEPHEN P. · Officer Title SVP & CFO · Transaction Code S

Traded Aug 31, 2026 · Disclosed Sep 1, 2026

Source: SEC Form 4 · 0001674236-26-000022 · filed 2026-09-01 · View filing →

SEC FORM 4
$0.00

ANI PHARMACEUTICALS INC (ANIP)

Acquisition (code A) of 6,662 shares at $0 per share.

Reporting Person Gosebruch Henry O · Transaction Code A

Traded Aug 19, 2026 · Disclosed Aug 27, 2026FILED +8 DAYS

Source: SEC Form 4 · 0001659625-26-000011 · filed 2026-08-27 · View filing →

SEC FORM 4
$401,220.00

ANI PHARMACEUTICALS INC (ANIP)

Sale of 5,400 shares at $74.30 per share.

Reporting Person Lalwani Nikhil · Officer Title PRESIDENT & CEO · Transaction Code S

Traded Aug 25, 2026 · Disclosed Aug 26, 2026

Source: SEC Form 4 · 0001822629-26-000014 · filed 2026-08-26 · View filing →

SEC FORM 4
$37,740.00

ANI PHARMACEUTICALS INC (ANIP)

Sale of 500 shares at $75.48 per share.

Reporting Person Cook Meredith · Officer Title SR. VP, GENERAL COUNSEL & SEC. · Transaction Code S

Traded Aug 13, 2026 · Disclosed Aug 13, 2026

Source: SEC Form 4 · 0001938861-26-000023 · filed 2026-08-13 · View filing →